{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:31:58Z","timestamp":1792679518554,"version":"4.5.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary pulmonary hypertension (PPH) is a rare and fatal disease of unknown etiology. Inflammatory oxidant mechanisms and deficiency in nitric oxide (NO) have been implicated in the pathogenesis of pulmonary hypertension. In order to investigate abnormalities in oxidants and antioxidants in PPH, we studied intrapulmonary NO levels, biochemical reaction products of NO, and antioxidants (glutathione [GSH], glutathione peroxidase [GPx], and superoxide dismutase [SOD]) in patients with PPH (n = 8) and healthy controls (n = 8). Intrapulmonary gases and fluids were sampled at bronchoscopy. Pulmonary hypertension was determined by right-heart catheterization. NO and biochemical reaction products of NO in the lung were decreased in PPH patients in comparison with healthy controls (NO [ppb] in airway gases: control, 8 \u00b1 1; PPH, 2.8 \u00b1 0.9; p = 0.016; and NO products [ \u03bc M] in bronchoalveolar lavage fluid [BALF]: control, 3.3 \u00b1 1.05; PPH, 0.69 \u00b1 0.21; p = 0.03). However, GSH in the lungs of PPH patients was higher than in those of controls (GSH [ \u03bc M] in BALF: 0.55 \u00b1 0.04; PPH, 0.9 \u00b1 0.1; p = 0.015). SOD and GPx activities were similar in the two groups (p \u2265 0.50). Biochemical reaction products of NO were inversely correlated with pulmonary artery pressures (R = \u2212 0.713; p = 0.047) and with years since diagnosis of PPH (R = \u2212 0.776; p = 0.023). NO reaction products are formed through interactions between oxidants and NO, with the end products of reaction dependent upon the relative levels of the two types of molecules. The findings of the study therefore show that NO and oxidant reactions in the lung are related to the increased pulmonary artery pressures in PPH.<\/jats:p>","DOI":"10.1164\/ajrccm.158.3.9802066","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:45:28Z","timestamp":1365083128000},"page":"917-923","source":"Crossref","is-referenced-by-count":199,"title":["Biochemical Reaction Products of Nitric Oxide as Quantitative Markers of Primary Pulmonary Hypertension"],"prefix":"10.1093","volume":"158","author":[{"given":"F. TAKAO","family":"KANEKO","sequence":"first","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALEJANDRO C.","family":"ARROLIGA","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAED A.","family":"DWEIK","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUZY A.","family":"COMHAIR","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIEL","family":"LASKOWSKI","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RITA","family":"OPPEDISANO","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARY JANE","family":"THOMASSEN","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SERPIL C.","family":"ERZURUM","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1998,9,1]]},"reference":[{"key":"2026032709091023500_B1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension.","volume":"336","author":"Rubin","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"2026032709091023500_B2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension, results from a national prospective registry.","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"2026032709091023500_B3","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.89.4.1733","article-title":"Survival in primary pulmonary hypertension, validation of a prognostic equation.","volume":"89","author":"Sandoval","year":"1994","journal-title":"Circulation"},{"key":"2026032709091023500_B4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.","volume":"333","author":"Giaid","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2026032709091023500_B5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.CIR.89.5.2035","article-title":"Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.","volume":"89","author":"Stamler","year":"1994","journal-title":"Circulation"},{"key":"2026032709091023500_B6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.CIR.93.2.266","article-title":"Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans.","volume":"93","author":"Cooper","year":"1996","journal-title":"Circulation"},{"key":"2026032709091023500_B7","first-page":"H562","article-title":"Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow.","volume":"271","author":"Reddy","year":"1996","journal-title":"Am. J. Physiol."},{"key":"2026032709091023500_B8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0735-1097(96)00218-5","article-title":"Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans.","volume":"28","author":"Blitzer","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"2026032709091023500_B9","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/thx.48.10.1034","article-title":"Nitric oxide and lung disease.","volume":"48","author":"Barnes","year":"1993","journal-title":"Thorax"},{"key":"2026032709091023500_B10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0006-291X(91)91268-H","article-title":"Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans.","volume":"181","author":"Gustafsson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026032709091023500_B11","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.92.17.7809","article-title":"Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.","volume":"92","author":"Guo","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026032709091023500_B12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1165\/ajrcmb\/9.4.371","article-title":"Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization.","volume":"9","author":"Kobzik","year":"1993","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2026032709091023500_B13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1378\/chest.111.1.44","article-title":"Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis.","volume":"111","author":"Riley","year":"1997","journal-title":"Chest"},{"key":"2026032709091023500_B14","first-page":"547","article-title":"Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity.","volume":"87","author":"Cremona","year":"1994","journal-title":"Q. J. Med."},{"key":"2026032709091023500_B15","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1056\/NEJM199512143332416","article-title":"Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.","volume":"333","author":"Xue","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2026032709091023500_B16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.HYP.28.5.743","article-title":"Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat.","volume":"28","author":"Xue","year":"1996","journal-title":"Hypertension"},{"key":"2026032709091023500_B17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(91)92033-X","article-title":"Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.","volume":"338","author":"Pepke-Zaba","year":"1991","journal-title":"Lancet"},{"key":"2026032709091023500_B18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.","volume":"336","author":"The Neonatal Inhaled Nitric Oxide Study Group","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"2026032709091023500_B19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn.","volume":"336","author":"Roberts","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"2026032709091023500_B20","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.","volume":"144","author":"Tuder","year":"1994","journal-title":"Am. J. Pathol."},{"key":"2026032709091023500_B21","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.","volume":"151","author":"Humbert","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032709091023500_B22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1056\/NEJM199708283370904","article-title":"Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine.","volume":"337","author":"Mark","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"2026032709091023500_B23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0070-2137(96)80006-9","article-title":"Chemical biology of nitric oxide: regulation and protective and toxic mechanisms.","volume":"34","author":"Wink","year":"1996","journal-title":"Curr. Top. Cell Regul."},{"key":"2026032709091023500_B24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/ajrccm.149.2.7508323","article-title":"The biology of nitrogen oxides in the airways.","volume":"149","author":"Gaston","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032709091023500_B25","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1073\/pnas.94.13.6954","article-title":"Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages.","volume":"94","author":"Xia","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026032709091023500_B26","first-page":"108","article-title":"A radical vascular connection.","volume":"380","author":"Stamler","year":"1996","journal-title":"Nature"},{"key":"2026032709091023500_B27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension: a national prospective study.","volume":"107","author":"Stuart","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"2026032709091023500_B28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1172\/JCI1378","article-title":"Nitric oxide synthesis in the lung: regulation by oxygen through a kinetic mechanism.","volume":"101","author":"Dweik","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2026032709091023500_B29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI119598","article-title":"Interferon-\u03b3 and interleukin-4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators.","volume":"100","author":"Guo","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2026032709091023500_B30","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1152\/jappl.1993.75.3.1256","article-title":"In vivo antioxidant gene expression in human airway epithelium of normal individuals exposed to 100% O2.","volume":"75","author":"Erzurum","year":"1993","journal-title":"J. Appl. Physiol."},{"key":"2026032709091023500_B31","doi-asserted-by":"crossref","first-page":"L148","DOI":"10.1152\/ajplung.1997.272.1.L148","article-title":"Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo.","volume":"272","author":"De Raeve","year":"1997","journal-title":"Am. J. Physiol. (Lung Cell Mol. Physiol.)"},{"key":"2026032709091023500_B32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-3565(25)22134-6","article-title":"Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress.","volume":"227","author":"Adams","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026032709091023500_B33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(25)13024-3","article-title":"Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells.","volume":"253","author":"Chung","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026032709091023500_B34"},{"key":"2026032709091023500_B35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"2026032709091023500_B36","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026032709091023500_B37","first-page":"287","article-title":"Mammalian nitric oxide synthases.","volume":"65","author":"Stuehr","year":"1992","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"2026032709091023500_B38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.HYP.16.2.162","article-title":"H2O2 and endothelium-dependent cerebral arteriolar dilation; implications for the identity of endothelium-derived relaxing factor generated by acetylcholine.","volume":"16","author":"Wei","year":"1990","journal-title":"Hypertension"},{"key":"2026032709091023500_B39","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1152\/jn.1997.78.4.2072","article-title":"Intravenous morphine increases release of nitric oxide from spinal cord by an \u03b1-adrenergic and cholinergic mechanism.","volume":"78","author":"Zemin","year":"1997","journal-title":"J. Neurophysiol."},{"key":"2026032709091023500_B40","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.4049\/jimmunol.156.12.4845","article-title":"Morphine induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide.","volume":"156","author":"Magazine","year":"1996","journal-title":"J. Immunol."},{"key":"2026032709091023500_B41","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI118332","article-title":"Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen.","volume":"96","author":"Liao","year":"1995","journal-title":"J. Clin. Invest."},{"key":"2026032709091023500_B42","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1084\/jem.182.6.1683","article-title":"A hypoxia responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.","volume":"182","author":"Melillo","year":"1995","journal-title":"J. Exp. Med."},{"key":"2026032709091023500_B43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000441-199402000-00010","article-title":"Significance of glutathione in lung disease and implications for therapy.","volume":"307","author":"Morris","year":"1994","journal-title":"Am. J. Med. Sci."},{"key":"2026032709091023500_B44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02714149","article-title":"Glutathione and inflammatory disorders of the lung.","volume":"169","author":"Cantin","year":"1991","journal-title":"Lung"},{"key":"2026032709091023500_B45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1152\/jappl.1987.63.1.152","article-title":"Normal alveolar epithelial lining fluid contains high levels of glutathione.","volume":"63","author":"Cantin","year":"1987","journal-title":"J. Appl. Physiol."},{"key":"2026032709091023500_B46","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1461","article-title":"Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma.","volume":"147","author":"Smith","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709091023500_B47","first-page":"286","article-title":"Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-\u03b2.","volume":"144","author":"Botney","year":"1994","journal-title":"Am. J. Pathol."},{"key":"2026032709091023500_B48","first-page":"1140","article-title":"Active macrophage-associated TGF-\u03b2 co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries.","volume":"146","author":"Bahadori","year":"1995","journal-title":"Am. J. Pathol."},{"key":"2026032709091023500_B49","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.","volume":"328","author":"Giaid","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"2026032709091023500_B50","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increase plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?","volume":"114","author":"Stewart","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"2026032709091023500_B51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension.","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N. Engl. J. Med."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/158\/3\/917\/67454016\/ajrccm_158_3_917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/158\/3\/917\/67454016\/ajrccm_158_3_917.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:09:21Z","timestamp":1774616961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/158\/3\/917\/8532488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9,1]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1998,9,1]]},"published-print":{"date-parts":[[1998,9,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.158.3.9802066","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,9]]},"published":{"date-parts":[[1998,9,1]]}}}